|
1
|
Ferlay J, Soerjomataram I, Dikshit R, Eser
S, Mathers C, Rebelo M, Parkin DM, Forman D and Bray F: Cancer
incidence and mortality worldwide: Sources, methods and major
patterns in GLOBOCAN 2012. Int J Cancer. 136:E359–E386. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Forner A, Llovet JM and Bruix J:
Hepatocellular carcinoma. Lancet. 31:1245–1255. 2012. View Article : Google Scholar
|
|
3
|
Schlachterman A, Craft WW Jr, Hilgenfeldt
E, Mitra A and Cabrera R: Current and future treatments for
hepatocellular carcinoma. World J Gastroenterol. 21:8478–8491.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Kalogeridi MA, Zygogianni A, Kyrgias G,
Kouvaris J, Chatziioannou S, Kelekis N and Kouloulias V: Role of
radiotherapy in the management of hepatocellular carcinoma: A
systematic review. World J Hepatol. 7:101–112. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Lee IJ and Seong J: Radiotherapeutic
strategies in the management of hepatocellular carcinoma. Oncology.
81 Suppl 1:S123–S133. 2011. View Article : Google Scholar
|
|
6
|
Nath S and Mukherjee P: MUC1: A
multifaceted oncoprotein with a key role in cancer progression.
Trends Mol Med. 20:332–342. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Kitamoto S, Yokoyama S, Higashi M, Yamada
N, Takao S and Yonezawa S: MUC1 enhances hypoxia-driven
angiogenesis through the regulation of multiple proangiogenic
factors. Oncogene. 32:4614–4621. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Gronnier C, Bruyère E, Lahdaoui F,
Jonckheere N, Perrais M, Leteurtre E, Piessen G, Mariette C and Van
Seuningen I: The MUC1 mucin regulates the tumorigenic properties of
human esophageal adenocarcinomatous cells. Biochim Biophys Acta.
1843:2432–2437. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Wang J, Liu G, Li Q, Wang F, Xie F, Zhai
R, Guo Y, Chen T, Zhang N, Ni W, et al: Mucin1 promotes the
migration and invasion of hepatocellular carcinoma cells via
JNK-mediated phosphorylation of Smad2 at the C-terminal and linker
regions. Oncotarget. 6:19264–19278. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Zhao Q, Piyush T, Chen C, Hollingsworth
MA, Hilkens J, Rhodes JM and Yu LG: MUC1 extracellular domain
confers resistance of epithelial cancer cells to anoikis. Cell
Death Dis. 5:e14382014. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Mohr AM, Bailey JM, Lewallen ME, Liu X,
Radhakrishnan P, Yu F, Tapprich W and Hollingsworth MA: MUC1
regulates expression of multiple microRNAs involved in pancreatic
tumor progression, including the miR-200c/141 cluster. PLoS One.
8:e733062013. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Nath S, Daneshvar K, Roy LD, Grover P,
Kidiyoor A, Mosley L, Sahraei M and Mukherjee P: MUC1 induces drug
resistance in pancreatic cancer cells via upregulation of multidrug
resistance genes. Oncogenesis. 2:e512013. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Kharbanda A, Rajabi H, Jin C, Raina D and
Kufe D: Oncogenic MUC1-C promotes tamoxifen resistance in human
breast cancer. Mol Cancer Res. 11:714–723. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Zhou B, Chen H, Wei D, Kuang Y, Zhao X, Li
G, Xie J and Chen P: A novel miR-219-SMC4-JAK2/Stat3 regulatory
pathway in human hepatocellular carcinoma. J Exp Clin Cancer Res.
33:552014. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Huang CY, Lin CS, Tai WT, Hsieh CY, Shiau
CW, Cheng AL and Chen KF: Sorafenib enhances radiation-induced
apoptosis in hepatocellular carcinoma by inhibiting STAT3. Int J
Radiat Oncol Biol Phys. 86:456–462. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Li Y, Dinwiddie DL, Harrod KS, Jiang Y and
Kim KC: Anti-inflammatory effect of MUC1 during respiratory
syncytial virus infection of lung epithelial cells in vitro. Am J
Physiol Lung Cell Mol Physiol. 298:L558–L563. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) Method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Chen Q, Li D, Ren J, Li C and Xiao ZX:
MUC1 activates JNK1 and inhibits apoptosis under genotoxic stress.
Biochem Biophys Res Commun. 440:179–183. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Wei X, Xu H and Kufe D: Human MUC1
oncoprotein regulates p53-responsive gene transcription in the
genotoxic stress response. Cancer Cell. 7:167–178. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Yin L, Kharbanda S and Kufe D: Mucin 1
oncoprotein blocks hypoxia-inducible factor 1alpha activation in a
survival response to hypoxia. J Biol Chem. 282:257–266. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Yin L, Kharbanda S and Kufe D: MUC1
oncoprotein promotes autophagy in a survival response to glucose
deprivation. Int J Oncol. 34:1691–1699. 2009.PubMed/NCBI
|
|
22
|
Balcer-Kubiczek EK: Apoptosis in radiation
therapy: A double-edged sword. Exp Oncol. 34:277–285.
2012.PubMed/NCBI
|
|
23
|
Tréhoux S, Duchêne B, Jonckheere N and Van
Seuningen I: The MUC1 oncomucin regulates pancreatic cancer cell
biological properties and chemoresistance. Implication of p42-44
MAPK, Akt, Bcl-2 and MMP13 pathways. Biochem Biophys Res Commun.
456:757–762. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Xu X, Wells A, Padilla MT, Kato K, Kim KC
and Lin Y: A signaling pathway consisting of miR-551b, catalase and
MUC1 contributes to acquired apoptosis resistance and
chemoresistance. Carcinogenesis. 35:2457–2466. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Castorina A and Giunta S: Mucin 1 (MUC1)
signalling contributes to increase the resistance to cell death in
human bronchial epithelial cells exposed to nickel acetate.
Biometals. 27:1149–1158. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Liu H, Tekle C, Chen YW, Kristian A, Zhao
Y, Zhou M, Liu Z, Ding Y, Wang B, Mælandsmo GM, et al: B7-H3
silencing increases paclitaxel sensitivity by abrogating Jak2/Stat3
phosphorylation. Mol Cancer Ther. 10:960–971. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Lee DH, Sung KS, Bartlett DL, Kwon YT and
Lee YJ: HSP90 inhibitor NVP-AUY922 enhances TRAIL-induced apoptosis
by suppressing the JAK2-STAT3-Mcl-1 signal transduction pathway in
colorectal cancer cells. Cell Signal. 27:293–305. 2015. View Article : Google Scholar : PubMed/NCBI
|
